护士主导照护在ACPA/RF阳性活动性类风湿关节炎达标治疗中的非劣效性随机对照试验
这项多中心实用随机对照试验纳入224例ACPA/RF阳性活动性RA患者,随机接受护士主导照护(NLC)或风湿科医生主导照护(RLC),随访12个月。两组DAS28-CRP改善均显著(p<0.001),组间无显著差异(p=0.317),NLC在主要和所有次要结局上均显示非劣效性。
要点
- NLC在主要结局DAS28-CRP上非劣效于RLC,非劣效界值0.6。
- 两组12个月内疾病活动度均显著改善(p<0.001),组间差异无统计学意义(p=0.317)。
- NLC在焦虑、抑郁和患者满意度等所有次要结局上均非劣效。
核心结论
- 在ACPA/RF阳性活动性RA患者中,护士主导照护在达标治疗和随访管理方面非劣效于风湿科医生主导照护。
研究设计与样本
- 多中心、实用随机对照试验,采用非劣效性设计,共纳入224例ACPA/RF阳性活动性RA成人患者,随机分为NLC组(n=111)和RLC组(n=113)。
- 主要结局为基线和第3、6、9、12个月评估的DAS28-CRP,非劣效界值为0.6,采用符合方案集和意向性治疗策略分析组间平均差异。
主要发现
- 两组12个月内DAS28-CRP改善均显著(p<0.001),NLC组与RLC组间无显著差异(p=0.317)。
- NLC在主要结局和所有次要结局上均显示非劣效性。
关键数值与推荐
- 非劣效界值为DAS28-CRP差异0.6。
- 主要结局组间比较p=0.317,两组内改善p<0.001。
临床怎么用
- 对于ACPA/RF阳性、中高疾病活动度且预后不良因素阳性的RA患者,在达标治疗策略下可考虑护士主导照护作为风湿科医生主导照护的替代或补充。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the non-inferiority of nurse-led care (NLC) in patients with anticitrullinated protein antibody (ACPA)-positive and/or rheumatoid factor (RF)-positive rheumatoid arthritis (RA) with active disease who are starting disease-modifying antirheumatic drug therapy, following treat-to-target (T2T) recommendations. METHODS: A multicentre, pragmatic randomised controlled trial was conducted to assess clinical effectiveness, anxiety, depression and patient satisfaction following a non-inferiority design. The participants were 224 adults with ACPA/RF-positive RA who were randomly assigned to either NLC or rheumatologist-led care (RLC). The primary outcome was the Disease Activity Score in 28 Joints measured with C reactive protein (DAS28-CRP) assessed at baseline and after 3, 6, 9 and 12 months. A DAS28-CRP difference of 0.6 was set as the non-inferiority margin. Mean differences between the groups were assessed following per-protocol and intention-to-treat strategies. RESULTS: Demographic data and baseline characteristics of patients in the NLC group (n=111) were comparable to those of patients in the RLC group (n=113). The improvement in disease activity (change in DAS28-CRP, primary outcome) over the course of 12 months was significant in both groups (p<0.001). No significant differences were observed between the NLC and RLC groups (p=0.317). Non-inferiority of NLC was shown for the primary outcome and all secondary outcomes. CONCLUSION: This study supported the non-inferiority of NLC in managing T2T and follow-up care of patients with RA with moderate to high disease activity and poor prognostic factors in addition to RLC. TRIAL REGISTRATION NUMBER: DRKS00013055.
引用
- Hoeper JR, Zeidler J, Meyer SE, et al. Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled trial. RMD Open. 2021. PMID: 33863842. doi:10.1136/rmdopen-2021-001627
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。